Eluga Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 75.00 K
as on 18-12-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 18-12-2024
- Revenue -4.91%
(FY 2023)
- Profit 20.66%
(FY 2023)
- Ebitda 69.22%
(FY 2023)
- Net Worth -44.82%
(FY 2023)
- Total Assets -69.79%
(FY 2023)
About Eluga Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 75.00 K .
The company currently has active open charges totaling ₹1.00 M.
Amar Deka, Sharmistha Majumder, and Upama Deka serve as directors at the Company.
- CIN/LLPIN
U85300WB2019PTC232468
- Company No.
232468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Eluga Healthcare Private Limited offer?
Eluga Healthcare Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Disinfectant Chemicals.
Who are the key members and board of directors at Eluga Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Deka  | Director | 14-Jun-2019 | Current |
| Sharmistha Majumder | Director | 01-Apr-2024 | Current |
| Upama Deka | Director | 20-Nov-2023 | Current |
Financial Performance of Eluga Healthcare.
Eluga Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.91% decrease. The company also saw a substantial improvement in profitability, with a 20.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eluga Healthcare?
Unlock access to Eluga Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Sep 2024 | ₹1.00 M | Open |
How Many Employees Work at Eluga Healthcare?
Unlock and access historical data on people associated with Eluga Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eluga Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eluga Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
